Showing 1 - 6 results of 6 for search 'Felipe Samaniego', query time: 0.03s Refine Results
  1. 1
    Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma

    Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma by Yasuhiro Oki, Anas Younes, Javier Knickerbocker, Felipe Samaniego, Loretta Nastoupil, Fredrick Hagemeister, Jorge Romaguera, Nathan Fowler, Larry Kwak, Jason Westin

    Published 2015-07-01
    Get full text
    Article
  2. 2
    Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs

    Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs by Rohit Mathur, Lalit Sehgal, Ondrej Havranek, Stefan Köhrer, Tamer Khashab, Neeraj Jain, Jan A. Burger, Sattva S. Neelapu, R. Eric Davis, Felipe Samaniego

    Published 2017-02-01
    Get full text
    Article
  3. 3
    Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphoma

    Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphoma by Nathan H. Fowler, Loretta J. Nastoupil, Frederick B. Hagemeister, Sattva S. Neelapu, Luis E. Fayad, Denise LeBlanc, Felipe Samaniego, Chan Yoon Cheah

    Published 2015-11-01
    Get full text
    Article
  4. 4
    Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma

    Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma by Paolo Strati, Mohamed Amin Ahmed, Nathan H. Fowler, Loretta J. Nastoupil, Felipe Samaniego, Luis E. Fayad, Fredrick B. Hagemeister, Jorge E. Romaguera, Alma Rodriguez, Michael Wang, Jason R. Westin, Chan Cheah, Mansoor Noorani, Lei Feng, Richard E. Davis, Sattva S. Neelapu

    Published 2020-07-01
    Get full text
    Article
  5. 5
    A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma

    A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma by Paolo Strati, Dai Chihara, Yasuhiro Oki, Luis E Fayad, Nathan Fowler, Loretta Nastoupil, Jorge E Romaguera, Felipe Samaniego, Naveen Garg, Lei Feng, Emily T. Wesson, Charnelle E. Ruben, Mildred D. Stafford, Yago Nieto, Issa F Khouri, Chitra Hosing, Sandra B. Horowitz, Rammurti T-. Kamble, Michelle A. Fanale

    Published 2018-09-01
    Get full text
    Article
  6. 6
    Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma

    Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma by Paolo Strati, Ankur Varma, Sherry Adkins, Loretta J. Nastoupil, Jason Westin, Fredrick B. Hagemeister, Nathan H. Fowler, Hun J. Lee, Luis E. Fayad, Felipe Samaniego, Sairah Ahmed, Yiming Chen, Sandra Horowitz, Sara Arafat, Swapna Johncy, Partow Kebriaei, Victor Eduardo Mulanovich, Ella Ariza Heredia, Sattva S. Neelapu

    Published 2020-07-01
    Get full text
    Article

Search Tools: